Valuation, from the filing
| Public float | $24.20B | Market value of stock held by non-affiliates, as stated on the cover page for 2025-06-30 |
|---|---|---|
| Float per share | $1,190.64 | Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself. |
| Float / net income | 27.8× | A lower bound on the multiple, because affiliate holdings are excluded. |
| Float / revenue | 6.0× | A lower bound on the multiple, because affiliate holdings are excluded. |
Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.
Valuation over time
27.8× earnings today, against a median of 33.2× across 10 years on record. Below its own history.
| Float measured | Public float | Float / net income | |
|---|---|---|---|
| 2025-06-30 | $24.20B | 27.8× | |
| 2024-06-30 | $29.70B | 34.4× | |
| 2023-06-30 | $28.70B | 36.4× | |
| 2022-06-30 | $25.90B | 29.7× | |
| 2021-06-30 | $32.00B | 41.6× | |
| 2020-06-30 | $19.30B | 32.0× | |
| 2019-06-30 | $20.70B | 36.9× | |
| 2018-06-30 | $14.59B | 28.5× | |
| 2017-06-30 | $15.10B | 40.2× | |
| 2016-06-30 | $9.70B | 25.2× |
Each float is paired with the fiscal year the filing that stated it covers. Only years where the company reported positive net income appear, because a multiple against a loss is not a multiple.
How this compares in its industry
Percentile among the Laboratory Analytical Instruments filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.
| Measure | Reported | Percentile | |
|---|---|---|---|
| Current ratio | 1.14x | 0th | |
| R&D / revenue | 5.0% | 0th | |
| SBC / revenue | 0.6% | 0th | |
| FCF margin | 21.1% | 94th | |
| Net margin | 21.6% | 91th | |
| Gross margin | 59.4% | 89th | |
| CapEx / revenue | 2.7% | 63th | |
| Revenue YoY growth | 4.0% | 55th | |
| Effective tax rate | 17.1% | 50th |
METTLER TOLEDO INTERNATIONAL INC/ (MTD) reported revenue of $4.13B and net income of $905.61M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from METTLER TOLEDO INTERNATIONAL INC/’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Laboratory Analytical Instruments.
Income
| Metric | 2026-06-30 |
|---|---|
| Revenue | $4.13B |
| Cost of revenue | Unavailable |
| Gross profit | $2.49B |
| Operating income | Unavailable |
| Net income | $905.61M |
| Research & development | $208.01M |
| Weighted-average diluted shares | Unavailable |
| Pretax income | $1.10B |
| Income tax expense | $191.76M |
| Diluted EPS | Unavailable |
| Selling, general & administrative | $1.03B |
| General & administrative | Unavailable |
| Selling & marketing | Unavailable |
Balance
| Metric | 2026-06-30 |
|---|---|
| Cash & equivalents | $51.38M |
| Total assets | $3.67B |
| Current assets | $1.35B |
| Total liabilities | $3.66B |
| Current liabilities | $1.20B |
| Total equity incl. NCI | $12.82M |
| Temporary (mezzanine) equity | Unavailable |
| Inventory | $411.56M |
| Accounts receivable | $731.48M |
| Goodwill | $735.21M |
| Long-term debt | $2.04B |
| Accounts payable | $229.80M |
Cash flow
| Metric | 2026-06-30 |
|---|---|
| Operating cash flow | $975.17M |
| Capital expenditures | $111.20M |
| Investing cash flow | -$172.61M |
| Financing cash flow | -$817.11M |
| Net change in cash | -$10.44M |
| Stock-based compensation | $22.83M |
| Common dividends paid | Unavailable |
| Common share repurchases | $775.00M |
| Depreciation & amortization | Unavailable |
Derived
| Metric | 2026-06-30 |
|---|---|
| Free cash flow | $863.97M |
| Gross margin | 60.3% |
| Operating margin | Unavailable |
| FCF margin | 20.9% |
| SBC / revenue | 0.6% |
| Current ratio | 1.12x |
| Revenue YoY growth | 6.9% |
| Net margin | 21.9% |
| R&D / revenue | 5.0% |
| CapEx / revenue | 2.7% |
| Long-term debt / equity | 159.45x |
| Effective tax rate | 17.5% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open MTD in the interactive workspace to inspect any figure back to its filing.
Source filings
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.